Nitrite-reductase (NIRB) as potential anti-tubercular target and a method to detect the severity of tuberculosis disease
Abstract:
The present invention discloses functional nitrite reductase as a potential drug target for anti-tubercular drug development. The present invention also relates to the development of an easy method for identification of nitrite in clinical samples as well as its correlation with the severity of the disease. Presence of active as well as dormant/latent stages of Mycobacterium tuberculosis (MTB) could be identified from nitrite in clinical samples like sputum of potential TB patients.
Information query
Patent Agency Ranking
0/0